UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT06698744 · WITHDRAWN

Trial details

NCT number: NCT06698744
Sponsor: David Wald
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Multiple Myeloma in Relapse Multiple Myeloma, Refractory

Start date: 2025-09-01
Primary completion: 2026-12-11
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.